ClinicalTrials.gg
Sign In
CompletedNCT06682338Updated Nov 12, 2024

Psychological Impact of Armed Conflict on Sudanese Diabetic Patients 2024

An observational study in Psychological Impact of Armed Conflict and Diabetes Complications, sponsored by Rayan Jamal Yousif Khidir. Completed at 1 site in Sudan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-12.

Sponsored by Rayan Jamal Yousif Khidir · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
117
Ages
18 Years and older
Sex
All
01

Study summary

The study focused on Sudanese people with diabetes who experienced the ongoing war in Sudan. Some people were displaced and others were not. This would had an impact on their mental health. We have investigated this impact and any complications happened to them through Self-Administered questionnaire.

02

Conditions studied

  • Psychological Impact of Armed Conflict
  • Diabetes Complications

Keywords

  • DASS-21
  • Sudan
  • Psychological
  • Armed conflict
  • Diabetics
03

In context

Diabetes Complications

267 studies on the registry are indexed under Diabetes Complications; 54 are open to participants now.

This study's enrollment of 117 is below the median of 200 across 84 observational studies indexed under Diabetes Complications.

Browse Diabetes Complications studies →

Lead sponsor

This is the only study on the registry with Rayan Jamal Yousif Khidir as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Sudanese Diabetic Patients above 18 years old, of both genders, from Khartoum and Gezira states.

Eligibility criteria

Inclusion Criteria: Sudanese Diabetic Patients, both genders, above 18 years

-

Exclusion Criteria:

  • Non Diabetic, pre-existing psychological disorder
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
117 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Psychological Impact

    Measured by Depression Anxiety Stress Scale-21 questionnaire.

    Time frame: April 2024 - July 2024

Secondary outcomes

  1. Diabetes complications

    Measured by Self-Administered questionnaire containing questions about demographic data, patient's diabetes history and experienced complications

    Time frame: April 2024 - July 2024

07

Study locations

1 site
  • Research and Publication Office, Dental Alumni and Students Affairs, Karary University
    Omdurman, Khartoum, Sudan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2024 to primary completion in Jul 2024, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2024
First posted
Nov 12, 2024
StartActual
Apr 21, 2024
Primary completionActual
Jul 20, 2024
CompletionActual
Aug 20, 2024
Last update
Nov 12, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06682338
Lead sponsor
Rayan Jamal Yousif Khidir
Responsible party
Rayan Jamal Yousif Khidir (Leader of Public Health Group, Research and Publication office) — Sponsor-investigator
First posted
Nov 12, 2024
Start date
Apr 21, 2024
Primary completion
Jul 20, 2024
Completion
Aug 20, 2024
Last update
Nov 12, 2024

Study contacts

Alaa MAK Alshykh, BDS
study chair · Research and Publication Office, Dental Alumni and Students Affairs, Karary University
Mai AA Balal, BDS
study chair · Research and Publication Office, Dental Alumni and Students Affairs, Karary University
Mohamed HA Nasr, PhD
study director · International University of Africa / Omdurman Ahlia University
Afaf MH Jabir, BDS
study chair · Federal Ministry of Health, Sudan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Diabetes Complications →

Start the discussion